p48 Archives - NeuroNews International

First US patients treated with surface-modified p48 and p64 MW flow...

20 March 2026

WallabyPhenox announced today that the first US patients have successfully been treated in the PIANO investigational device exemption (IDE) trial evaluating the company’s p48 and p64...

Write to us
Editor: Jamie Bell [email protected]
Advertising: Abbie Richardson [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Tag: p48

First US patients treated with surface-modified p48 and p64 MW flow...